Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A licensed provider reviews your intake and determines what's appropriate
Ultimately, determining candidacy involves a comprehensive evaluation by healthcare professionals, taking into account both physical and mental health components to ensure safe and effective use
In clinical studies , adults with obesity or overweight (without type 2 diabetes) who took Wegovy lost around 15% of their body weight over 68 weeks
Historically, biosimilar peptide drugs see first US generic competition 12 to 24 months after patent expiration, assuming the regulatory pathway is established
This distinction leads to key differences in development and manufacturing: Peptide-based GLP-1 drugs require complex synthesis and formulation processes Small-molecule GLP-1 drugs are generally easier to manufacture at scale Oral bioavailability and stability present different technical challenges These differences highlight the contrasting development paths between peptide-based and small-molecule GLP-1 therapies, which continue to shape industry competition
